Three genuinely undervalued names this week, starting with an e-commerce and logistics company that just had its best week in months on AI logistics and Taiwan expansion news while still trading 30-40% below fair value.

Stay with this, and you will see two more regional banking setups where the cash flow math looks compelling.

Semiconductors

Micron Technology, Inc. (NASDAQ: MU), the memory and storage chipmaker closely tied to AI hardware demand, trades at around $1,074 after a sharp Monday rally. The move follows renewed concern that the global memory supply remains too tight, with the stock still trading at around 9.74x forward earnings, versus roughly 25.5x for the Nasdaq Composite.

That is not the usual valuation gap you expect from one of the hottest AI infrastructure names. The risk is obvious. Micron is still a memory stock, and memory stocks can look cheap exactly when earnings are peaking.

But this cycle is not being driven by normal PC and phone demand alone. AI servers are turning memory into a bottleneck, and investors are starting to treat DRAM and high-bandwidth memory less like commodity chips and more like critical infrastructure.

At this price, you get an AI supply-chain winner still valued as if the market is not fully sure the earnings base can hold.

Shortage Trade Gives the Rally Real Support

A one-day move can be noisy. A supply shortage tied to AI buildouts is a different story. When customers need more memory and supply cannot catch up quickly, pricing power can last longer than a normal cycle would suggest.

Forward Multiple Keeps the Case Interesting

A sub-10x forward multiple does not make Micron risk-free. It does make the stock harder to dismiss when earnings are still rising, and Q3 results are due June 24. If AI demand continues to stretch supply, the market may have to rethink how cheaply a cyclical leader should really trade.

Regional Banking

United Community Banks, Inc. (NYSE: UCB), the Southeast-focused regional bank, trades around $33.84 against a fresh $40 target, roughly 15% below that level. The target raise follows a $1.9 billion cash agreement to sell United's equipment finance business, consisting of Navitas Credit Corp. and NLFC Reinsurance Corp., at a 7% premium to the loan portfolio's par value.  That is not just a cleanup move. It changes the balance sheet conversation.

Navitas represented about 10% of United's total loan portfolio but accounted for about 50% of net charge-offs over the 12 months ended March 31. Selling it is expected to generate a $109 million one-time pre-tax earnings benefit, add roughly 3% to tangible book value per share, and lift CET1 capital by 145 basis points.

You get a regional bank priced as if investors still need proof that the cleaner credit story can hold.

Navitas Sale Removes a Real Credit Overhang

A business that is 10% of loans but about 50% of net charge-offs is exactly the kind of problem investors notice. Moving it out of the bank should make United's earnings quality easier to read.

Capital Boost Gives the Re-Rating Case More Structure

The sale does not eliminate normal banking risks such as deposit costs, credit cycles, or rate sensitivity. But a stronger CET1 position, tangible book accretion, and lower-risk reinvestment give management more flexibility. If the core Southeast bank can keep growing without the Navitas drag, the market may have to value UCB as more than another cautious regional lender.

Energy

Chevron Corporation (NYSE: CVX), the integrated energy major, trades around $180.11 against a $205.70 consensus target, roughly 12% below where analysts think the stock can go. The stock fell Monday as oil prices dropped after the U.S.-Iran peace framework reduced the supply-risk premium tied to the Strait of Hormuz.

This is not a clean “oil is going higher” story. Brent fell nearly 5% as traders priced in a lower chance of a prolonged supply disruption, and energy stocks took the hit. But Chevron is not just a crude-price trade. It is a global integrated energy company with upstream and downstream operations, cash returns, and a quarterly dividend of $1.78 per share.

After a geopolitical selloff, you get a dividend-backed oil major priced as if lower crude has already taken control of the story. 

Oil Pullback Tests the Energy Trade

A drop in crude can quickly reset earnings expectations, especially after a war premium fades. That is the risk. Chevron needs cash flow durability, not just higher spot prices, to keep the valuation case intact.

Consensus Gap Keeps the Setup From Looking One-Sided

A $205.70 consensus target is not a guarantee, but it matters when the stock is near $180 and the dividend yield is still close to 4%. If oil stabilizes rather than slides further, the market may have punished Chevron for a risk-premium unwind rather than a broken earnings base.

Metropolitan Bank Holding (NYSE: MCB) is a New York commercial bank trading around $94 against a future cash flow fair value estimate of $157.18, a significant gap, with a P/CF ratio of 6.52 against an industry average of 10.10.

Q1 2026 net interest income rose to $85.91 million with net income of $31.43 million, both growing year over year, and earnings are projected to grow significantly over the next three years.

This is a name where the cash flow math looks genuinely compelling, even with recent insider selling and board changes adding some near-term noise. The risk is that those board changes signal something about near-term credit quality that the cash flow model has not yet captured.

Comcast (NASDAQ: CMCSA) trades around $24.49 with a P/E ratio of 4.82 and a dividend yield of 5.4%, sitting near its 52-week low of $23.13 after a steep decline from a 52-week high of $34.66.

The cable and broadband business faces real cord-cutting pressure, but the connectivity infrastructure remains sticky, and the NBCUniversal and Peacock assets add optionality that a sub-5x earnings multiple is not pricing in.

At this multiple, you are paying a distressed price for a business generating substantial free cash flow and returning capital through dividends and buybacks. The risk is that broadband subscriber losses accelerate faster than the free cash flow story can absorb.

Prestige Consumer Healthcare (NYSE: PBH), maker of Clear Eyes, Dramamine, Monistat, and Summer’s Eve, trades around $49 against a GF Value of $67.85, a 27.6% discount, with the most-followed fair value narrative pegging it at $78.50 for a 66.55% intrinsic discount after the stock dropped 37% over the past year.

A completed $207 million buyback covering 6.24% of shares shows management thinks the stock is cheap too, and the brand portfolio remains category-leading in niche consumer health segments.

The risk is that larger competitors like Haleon and Kenvue use their scale to displace some of Prestige’s smaller brands faster than the buyback and brand strength can offset.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any [blank] stocks you want me to check out.

Best Regards,
—Noah Zelvis
Undervalued Edge